These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5300187)

  • 21. Discriminant analysis of the relationship between physical properties and the inhibition of monoamine oxidase by aminotetralins and aminoindans.
    Martin YC; Holland JB; Jarboe CH; Plotnikoff N
    J Med Chem; 1974 Apr; 17(4):409-13. PubMed ID: 4830537
    [No Abstract]   [Full Text] [Related]  

  • 22. Anticonvulsant, analgesic and monoamine oxidase inhibitory properties of newer 4-hydroxy-4-phenylpiperidinocarbamides.
    Pandey BR; Gupta AK; Raman K; Parmar SS
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):349-58. PubMed ID: 461959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The anticonvulsant action of carbon dioxide: interaction with reserpine and inhibitors of carbonic anhydrase.
    Gray WD; Rauh CE
    J Pharmacol Exp Ther; 1968 Oct; 163(2):431-8. PubMed ID: 5681182
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of central monoamines in decapitation convulsions of mice.
    Kamat UG; Sheth UK
    Neuropharmacology; 1971 Sep; 10(5):571-9. PubMed ID: 4399542
    [No Abstract]   [Full Text] [Related]  

  • 25. N-substituted cyclopropylamines as monoamine oxidase inhibitors. Structure-activity relationships. Dopa potentiation in mice and in vitro inhibition of kynuramine oxidation.
    Mills J; Kattau R; Slater IH; Fuller RW
    J Med Chem; 1968 Jan; 11(1):95-7. PubMed ID: 4384132
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of acylation with eleostearic acids on the monoamine oxidase inhibitory potency of some hydrazine antidepressants in mice.
    Hsu SY; Huang CL; Waters IW
    J Med Chem; 1975 Jan; 18(1):20-3. PubMed ID: 1109570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropharmacological studies on selective monoamine oxidase A and B inhibitors.
    Mukhopadhyay M; Upadhyay SN; Bhattacharya SK
    Indian J Exp Biol; 1987 Nov; 25(11):761-70. PubMed ID: 3133314
    [No Abstract]   [Full Text] [Related]  

  • 28. Proceedings: The effect of psychotropic drugs on the dopa potentiation test in mice.
    Berendsen H; Leonard BE; Rigter H
    Br J Pharmacol; 1974 Nov; 52(3):432P-433P. PubMed ID: 4458854
    [No Abstract]   [Full Text] [Related]  

  • 29. [Activity of toloxatone, antidepressive agents and various other reserpine antagonists on three behavior tests, in the mouse treated with nialamide].
    Gouret C; Raynaud G
    Therapie; 1975; 30(2):225-30. PubMed ID: 1080583
    [No Abstract]   [Full Text] [Related]  

  • 30. Relationship between CNS depressant and enzyme inhibitory properties of substituted quinazolone 1,3,4-oxadiazoles.
    Barthwal JP; Tandon SK; Agarwal VK; Dixit KS; Parmar SS
    J Pharm Sci; 1973 Apr; 62(4):613-7. PubMed ID: 4698982
    [No Abstract]   [Full Text] [Related]  

  • 31. Structure-activity relationships of monoamine oxidase inhibitors.
    Fujita T
    J Med Chem; 1973 Aug; 16(8):923-30. PubMed ID: 4745836
    [No Abstract]   [Full Text] [Related]  

  • 32. Synthesis of substituted anilino-(3-methoxy-4-(4-arylthiosemicarbazidocarbonylmethyleneoxy))benzylidenes: correlation between anticonvulsant activity and monoamine oxidase inhibitory and antihemolytic properties.
    Dwivedi C; Harbison RD; Ali B; Parmar SS
    J Pharm Sci; 1974 Jul; 63(7):1124-8. PubMed ID: 4854582
    [No Abstract]   [Full Text] [Related]  

  • 33. Anticonvulsant effect of phencarbamide and its modification by reserpine and tranylcypromine.
    Madan BR; Gupta RS; Pendse VK; Madan V
    Arch Int Pharmacodyn Ther; 1971 Mar; 190(1):155-8. PubMed ID: 4994549
    [No Abstract]   [Full Text] [Related]  

  • 34. Monoamine oxidase inhibitory and anticonvulsant properties of some newer thiosemicarbazones.
    Tripathi S; Pandey BR; Raman K; Barthwal JP; Kishor K; Bhargava KP
    Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):291-300. PubMed ID: 734217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relations between inhibition of cerebral monoamine oxidase in mice and the pyridoxal-5-phosphate-monoamine oxidase inhibitor pharmacological antagonism in the presence of 3,4-dihydroxyphenylalanine].
    Lévy J; Michel-Ber E
    J Physiol (Paris); 1965; 57(4):475-83. PubMed ID: 5848057
    [No Abstract]   [Full Text] [Related]  

  • 36. Anticonvulsant properties of diacetylmonoxime (DAM) and its effect on the facilitatory action of reserpine on convulsions.
    Galambos E; Pfeifer AK
    Psychopharmacologia; 1966; 9(3):248-52. PubMed ID: 5983211
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of methyldopa and related agents on pressor responses to tyramine in reserpine-pretreated rats and dogs.
    Torchiana ML; Wenger HC; Stavorski J; Ludden CT; Stone CA
    J Pharmacol Exp Ther; 1966 Feb; 151(2):242-52. PubMed ID: 5932601
    [No Abstract]   [Full Text] [Related]  

  • 38. Tricyclic antidepressives--a possible mode of action.
    Offermeier J; Potgieter B
    S Afr Med J; 1969 Nov; 43(45):1366-70. PubMed ID: 5358038
    [No Abstract]   [Full Text] [Related]  

  • 39. PS-2747: a new antidepressant agent.
    Plotnikoff N; Will F; Evans A; Meekma P
    Arch Int Pharmacodyn Ther; 1972 Feb; 195(2):330-42. PubMed ID: 4622667
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacologic effects of 2-phenylcycloalkylamines.
    McGrath WR; Kuhn WL
    Arch Int Pharmacodyn Ther; 1968 Apr; 172(2):405-13. PubMed ID: 5684251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.